Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY.
Covered in this story
What has happened since
- Morgan Stanley is down 12.8% since this was published, 51 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ADPT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Adaptive Biotechnologies Corp →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.